The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $6,856.47 Firm Fixed Price contract is for the supply of 4,564,402,667 Lisinopril 10 mg tablets, with a completion date of April 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
This federal contract award is for the delivery of Lisinopril 40 mg tablets in quantities of 1,000 to the U.S. government. The contract, valued at $3,503.44, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,088 units of Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,027.91 and a period of performance through October 15, 2024. AmerisourceBergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies, including a $999,999,999 IDC with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,058 units of the pharmaceutical drug Lisinopril 40 mg tablets. The $1,178.28 firm fixed-price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, with a period of performance through July 3, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90-count bottles of the 20 mg lisinopril tablet. The $2,220.25 firm fixed-price delivery order falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This federal contract award, with a value of $12,344.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,605,288 Lisinopril 10 mg tablets, a common blood pressure medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 15, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FG6V0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,569.66 firm fixed-price delivery order is for the provision of 4,565,482,416 units of the pharmaceutical drug Lisinopril-HCTZ 20-25 mg tablets. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...